Anduril is the most important private defense-tech company in the United States right now. A $5 billion Series H just doubled its valuation to $61 billion in under nine months, the U.S. Army signed a 10-year enterprise contract worth up to $20 billion, and revenue is compounding at triple-digit rates. This is no longer a startup — it is an emerging Prime contractor built on a software-native architecture. The core debate is whether public markets will value it as a tech-platform business at 14x forward revenue or compress it toward the 1.5–2x revenue multiples assigned to legacy Primes.
| Metric | Value |
|---|---|
| Current Valuation | $61.0B · May 2026 Series H |
| Prior Valuation | $30.5B · August 2025 Series G |
| Valuation Doubling Time | ~9 months |
| Total Capital Raised | $11.4B across all rounds |
| 2025 Revenue | $2.1B · +~110% YoY |
| 2026E Revenue | $4.3B · +~105% YoY |
| Forward Revenue Multiple | ~14× on 2026E |
| 2026E Operating Loss | ~$1.2B |
| Targeted EBITDA Breakeven | 2030 |
| Army Enterprise Contract | Up to $20B · 10-year (5+5) |
| Founders | Palmer Luckey · Trae Stephens · Brian Schimpf · Matt Grimm · Joe Chen |
| CEO | Brian Schimpf |
| Headquarters | Costa Mesa, California |
| Employees | ~5,000 |
| IPO Status | No imminent filing · rumored 2027 window |
Anduril raised $5 billion in its Series H in May 2026, doubling its valuation to $61 billion, led by Thrive Capital and Andreessen Horowitz. This follows the $30.5 billion Series G from August 2025 led by Founders Fund — meaning the company has doubled its private-market valuation in approximately nine months, a signal of both category momentum and investor conviction that an IPO is approaching.
The Series H brings Anduril's total raised to $11.4 billion across all rounds.
| Round | Date | Amount | Valuation | Lead |
|---|---|---|---|---|
| Series E | December 2022 | — | $8.5B | — |
| Series G | August 2025 | $2.5B | $30.5B | Founders Fund |
| Series H | May 2026 | $5.0B | $61.0B | Thrive Capital / a16z |
At $4.3 billion in projected 2026 revenue, the $61 billion valuation implies roughly ~14× forward revenue — a tech-sector multiple, not a defense-sector multiple. Legacy Primes (Lockheed Martin, Northrop Grumman, RTX) trade at roughly 1.5–2× revenue. That delta is the crux of the valuation debate that the IPO will price.
Anduril generated $2.1 billion in revenue in 2025, up roughly 110% from $1.0 billion in 2024, and is projecting $4.3 billion in revenue for 2026, driven by Arsenal-1 scaling production in Ohio.
| Year | Revenue | YoY Growth |
|---|---|---|
| 2024 | $1.0B | — |
| 2025 | $2.1B | ~+110% |
| 2026E | $4.3B | ~+105% |
The growth rate is extraordinary for a company of this scale. For context, Palantir (PLTR) — the most analogous public defense-tech comparable — took nearly 15 years to reach $2 billion in revenue. Anduril did it in 8.
Critical caveat: Anduril is projecting an operating loss of approximately $1.2 billion in 2026, with adjusted EBITDA profitability not expected until 2030, reflecting heavy upfront R&D and manufacturing investment across:
This is the classic Amazon / Tesla "invest now, harvest later" playbook — but it requires sustained capital access and contract visibility to work. The $11.4 billion raised to date and the $20 billion Army contract are the two pillars that make this credible.
This is the section where structural risk concerns dissolve fast.
In March 2026, the U.S. Army signed a 10-year contract with Anduril worth up to $20 billion, starting with a five-year base period and a five-year extension option. The contract consolidates more than 120 separate procurement actions for Anduril's commercial solutions into a single enterprise framework.
The contract structure is strategically important. A single enterprise vehicle that removes friction from 120+ individual procurement actions is a structural moat — it gives Anduril a near-captive spend channel with the Army while legacy competitors must still bid program-by-program.
Important caveat: the $20 billion is a contract ceiling, not obligated spend. Programs can still be restructured, descoped, or reallocated within the framework. But the structural advantage of being inside the perimeter — rather than competing for entry on every program — is the part that re-rates the long-term cash-flow profile.
Anduril is also part of the group building the $185 billion Golden Dome missile defense system for the U.S. government. Separately, the DoD announced an agreement with Anduril, CoAspire, Leidos, and Zone 5 to procure more than 10,000 low-cost hypersonic missiles over the next three years.
| Program | Scale | Status |
|---|---|---|
| Army Enterprise Contract | Up to $20B · 10-year | Signed · March 2026 |
| Golden Dome Missile Defense | $185B program | Announced participant |
| Hypersonic Missile Buy | 10,000+ units · 3 years | Multi-vendor agreement |
| Replicator Drone Program | Multi-billion DoD | Active |
Anduril's moat is the Lattice OS — a software-defined command-and-control platform that integrates every hardware system the company fields. This is the architectural play: sell the OS, then fill the platform with Anduril hardware over time.
| Product | Category | Status |
|---|---|---|
| 🧠 Lattice OS | Battlefield AI · Command & Control | Deployed across DoD |
| 🚀 Roadrunner | Kinetic interceptor drone | Active deployment |
| 🛸 Bolt | UAS (fixed-wing) | Fielded |
| 🚁 Ghost | Helicopter UAS | Fielded |
| 🗼 Sentry | Autonomous border / perimeter towers | Deployed |
| 🌊 Dive-LD | Long-duration subsea UUV | In service |
Lattice is the AI-enabled software system designed to integrate sensors, drones, radar networks, and battlefield intelligence into a single unified command-and-control interface. This is the strategic asset. Hardware can be commoditized; an OS that orchestrates every sensor and effector across a theater of war cannot.
Anduril is executing one of the most aggressive vertical-integration strategies in defense history:
This is not a software wrapper on government hardware — Anduril is industrializing the full defense stack. The capex commitment is enormous; the strategic positioning is unprecedented for a venture-backed company.
Anduril's approach reflects CEO Brian Schimpf's view that growing investor confidence in defense technology is driven by the U.S. and its allies facing mounting technological and industrial challenges tied to military modernization and evolving security threats — including great-power competition and the rise of autonomous warfare.
The key differentiator versus legacy Primes:
| Dimension | Anduril | Legacy Primes (LMT · NOC · RTX) |
|---|---|---|
| Development Cycle | 2–3 years | 10–15 years |
| R&D Funding | Self-funded (venture capital) | Government cost-plus |
| Revenue Model | Sell finished product | Develop-to-spec + milestone payments |
| Software Layer | Lattice OS (proprietary, end-to-end) | Fragmented / licensed |
| Valuation Multiple | ~14× fwd revenue | ~1.5–2× revenue |
| Profitability | Pre-profitability (2030 EBITDA target) | Profitable today |
The bull case: Anduril is compressing the defense cycle to Silicon Valley speed, and the Pentagon's proposed FY2027 budget of $1.5 trillion lists munitions as one of DoD's "highest funding priorities" — directly aligned with Anduril's Mississippi SRM facility and the 10,000-unit hypersonic missile buy.
The Series H doubles Anduril's valuation ahead of a widely anticipated IPO. Palmer Luckey has stated publicly that he would "definitely" take the company public.
The rumored 2027 IPO window aligns with the capital-raise cadence — three massive rounds in approximately three and a half years suggests Anduril is building the audited financial history and institutional investor base that typically precedes a public debut.
At $61 billion private, a public float would likely target $70–85 billion depending on profitability trajectory and broader market conditions — which would make it the largest defense-tech IPO in history, dwarfing Palantir's $15.8 billion direct listing in 2020.
| Milestone | Status | Detail |
|---|---|---|
| Series H closed | Done · May 2026 | $5B at $61B post-money · Thrive Capital + a16z lead |
| Audited financials build-out | In progress | Institutional investor base + reporting cadence consistent with pre-IPO discipline |
| Confidential S-1 (estimated) | 2026 H2 – 2027 H1 | Not filed as of May 2026 |
| Public Form S-1 on EDGAR | 2027 estimated | The actual catalyst event |
| Public listing | 2027 rumored | $70–85B target band |
| Risk | Severity | Detail |
|---|---|---|
| Profitability Gap | High | ~$1.2B projected 2026 operating loss · EBITDA breakeven not until 2030. Requires sustained capital access and contract visibility. |
| Contract Concentration | High | $20B Army enterprise vehicle is transformative but creates single-counterparty exposure to U.S. defense procurement cycles. |
| Program Restructuring | Medium | $20B Army ceiling ≠ obligated spend. Programs can be restructured or descoped within the enterprise framework. |
| Capital Burn vs Revenue Recognition | Medium | Multi-year contract revenue lags the upfront manufacturing capex by 12–36 months. |
| Multiple Compression | Medium | ~14× forward revenue vs ~1.5–2× for legacy Primes. Bear case is convergence toward defense-sector norms post-IPO. |
| Geopolitical / Budget Shift | Medium | Policy reversal or DoD budget realignment could compress contract flow. |
| Competitive Displacement | Low | Legacy Primes lack the software-native speed advantage. New entrants (Shield AI, others) compete on narrower verticals. |
The single most underwritten risk is the bridge from $1.2 billion in annual losses to 2030 EBITDA breakeven. The math only works if (a) the Army contract converts to obligated spend on schedule, (b) Arsenal-1 ramps to plan, and (c) the Mississippi SRM facility hits its 6,000-unit-per-year target. Any one of those slipping by 12+ months pushes the breakeven date and triggers an additional dilutive raise.
| Route | How | Caveats |
|---|---|---|
| Private secondary marketplaces | Private secondaries | Accredited investors only · post-Series-H pricing dynamic · illiquid |
| ARKVX | ARK Venture Fund holds an Anduril position | Closed-end · diffuse exposure across multiple privates |
| PLTR (Palantir) | Closest public comp for software-native defense exposure | Different product mix · already at premium multiple |
| LMT · NOC · RTX | Same DoD spending wave · compressed multiples | Slower-cycle businesses · different growth profile |
| Post-lockup window | 180 days after IPO | Historically the best risk-adjusted entry for high-growth IPO names |
Anduril is the most compelling private defense-tech investment opportunity in a generation — triple-digit revenue growth at $2 billion+ scale, a $20 billion enterprise Army contract, a $61 billion valuation with $11.4 billion raised, and a product architecture built around Lattice OS that could become the Android of the battlefield. The core risk is the profitability bridge: the company is burning approximately $1.2 billion per year to build manufacturing infrastructure that won't generate EBITDA until 2030. An IPO in 2027 at $70–85 billion would represent a significant liquidity event for holders — and a defining moment for the defense-tech category. For defense-sector investors, this is the pre-IPO name to watch most closely.